Enterotoxigenic B. fragilis robustly activates Th17 immune responses, which involves the inflammatory cytokine IL-17, and may lower host anti-tumor immune responses, encouraging unhindered tumor growth [97, 98]. This evidence concerns the gene IL17A and neoplasm.